DEXA: Clinical Trials

4 trials of DEXA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Recruiting 1
Phase 23Completed 2, Recruiting 1

Follow DEXA: new trials by email Literature Review of DEXA trials Research Report on DEXA

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint - Colorectal Carcinoma, Endometrial Carcinoma
Phase 1 / Phase 2RecruitingChildren's Oncology Group1472021-11-082026-08-25
Reducing Dexamethasone Around Docetaxel Infusion
Dexamethasone, Prednisone - Breast Cancer, Prostate Cancer
Phase 1CompletedLeiden University Medical Center462016-01-012026-02-17
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Rituximab, Conditioning chemotherapy, TMS - Myelodysplastic Syndromes, Hodgkin's Lymphoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)342015-09-242025-09-30
Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients
Perifosine, Bortezomib, Dexamethasone - Multiple Myeloma, Multiple Myeloma in Relapse
Phase 1 / Phase 2CompletedAEterna Zentaris842006-08-012018-02-23

Conditions studied

Lymphoma, Non-Hodgkin (2)  ·  Multiple Myeloma (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Colorectal Neoplasms (1)  ·  Desmoid Tumors (1)  ·  Endometrial Neoplasms (1)  ·  Hepatoblastoma (1)  ·  Hodgkin Disease (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Melanoma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neuroblastoma (1)  ·  Osteosarcoma (1)

Sponsors

AEterna Zentaris (1)  ·  Children's Oncology Group (1)  ·  Leiden University Medical Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Netherlands (1)

Top investigators

Alain Mina, M.D. (1)  ·  Paul Richardson, MD (1)  ·  Sarah B Whittle (1)

Results publications

PMID 21990396, PMID 40331908

NIH funding

2015 (1), UM1CA228823 (1)